Metraipolis › archive › dc_2d3e44243a66

Immune Checkpoint Inhibitor-Related Pancreatic Injury in Patients with Lung Cancer: Diagnostic Challenges, Multidisciplinary Management, and Outcomes — Europe PMC PMID:42794897

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42794897
DOI
10.3390/cancers18182930
License (as archived)
solo-consultazione
Archived
2026-10-15T18:15:19.311Z
SHA-256 of the archived text
3f8c4e2276038037071f746260432f48815178b2244cc31cbbadeb0717c2cfc8
Stable URL of this page
https://metraipolis.com/documento/dc_2d3e44243a66

How to cite

Immune Checkpoint Inhibitor-Related Pancreatic Injury in Patients with Lung Cancer: Diagnostic Challenges, Multidisciplinary Management, and Outcomes — Europe PMC PMID:42794897 — Europe PMC (en), https://europepmc.org/article/MED/42794897 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2d3e44243a66 (Metraipolis archive dc_2d3e44243a66, sha256 3f8c4e2276038037071f746260432f48815178b2244cc31cbbadeb0717c2cfc8)
BibTeX
@misc{dc2d3e44243a66,
  title = {Immune Checkpoint Inhibitor-Related Pancreatic Injury in Patients with Lung Cancer: Diagnostic Challenges, Multidisciplinary Management, and Outcomes — Europe PMC PMID:42794897},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42794897},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2d3e44243a66; sha256 3f8c4e2276038037071f746260432f48815178b2244cc31cbbadeb0717c2cfc8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42794897. Agents can read the archived copy with the MCP tool read_document.